2.52
price up icon26.00%   0.52
after-market 시간 외 거래: 2.58 0.06 +2.38%
loading
전일 마감가:
$2.00
열려 있는:
$2.27
하루 거래량:
952.15K
Relative Volume:
10.12
시가총액:
$181.68M
수익:
$5.15M
순이익/손실:
$-65.35M
주가수익비율:
-1.8667
EPS:
-1.35
순현금흐름:
$-20.85M
1주 성능:
+38.46%
1개월 성능:
+68.00%
6개월 성능:
+50.90%
1년 성능:
+22.93%
1일 변동 폭
Value
$2.27
$2.66
1주일 범위
Value
$1.77
$2.66
52주 변동 폭
Value
$1.10
$2.66

Cellectis Adr Stock (CLLS) Company Profile

Name
명칭
Cellectis Adr
Name
전화
-
Name
주소
-
Name
직원
222
Name
트위터
@cellectis
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CLLS's Discussions on Twitter

CLLS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CLLS
Cellectis Adr
2.52 200.65M 5.15M -65.35M -20.85M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Cellectis Adr Stock (CLLS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-03-17 개시 Bryan Garnier Buy
2022-05-18 업그레이드 Robert W. Baird Neutral → Outperform
2022-01-06 다운그레이드 Wells Fargo Overweight → Equal Weight
2021-11-30 개시 JMP Securities Mkt Outperform
2021-11-08 다운그레이드 William Blair Outperform → Mkt Perform
2021-10-08 다운그레이드 Robert W. Baird Outperform → Neutral
2021-04-28 다운그레이드 Guggenheim Buy → Neutral
2021-03-16 업그레이드 Robert W. Baird Neutral → Outperform
2020-08-19 업그레이드 Citigroup Neutral → Buy
2020-05-12 개시 Robert W. Baird Outperform
2020-03-06 다운그레이드 Goldman Neutral → Sell
2019-10-30 재개 Guggenheim Buy
2019-08-09 개시 BTIG Research Buy
2019-05-24 재개 Citigroup Neutral
2019-03-14 개시 William Blair Outperform
2018-12-19 개시 Goldman Neutral
2018-07-16 개시 Barclays Overweight
2018-03-16 개시 Guggenheim Neutral
2017-09-05 다운그레이드 SunTrust Buy → Hold
2017-09-05 재확인 Wells Fargo Outperform
2017-03-02 개시 Instinet Buy
2017-02-28 개시 Wells Fargo Outperform
2016-04-05 개시 Ladenburg Thalmann Buy
2016-03-02 개시 Sun Trust Rbsn Humphrey Buy
2015-07-20 개시 BofA/Merrill Buy
2015-04-20 개시 Jefferies Buy
2015-04-20 개시 Piper Jaffray Overweight
모두보기

Cellectis Adr 주식(CLLS)의 최신 뉴스

pulisher
Jul 23, 2025

European ADRs Inch Higher As Drugmakers Shine - Finimize

Jul 23, 2025
pulisher
Jul 21, 2025

Cellectis shares surge 66% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 16, 2025

European Stocks Falter On Wall Street As ADR Index Drops - Finimize

Jul 16, 2025
pulisher
Jul 03, 2025

European Equities Slip While Biopharma Stocks Shine - Finimize

Jul 03, 2025
pulisher
Jun 16, 2025

European Stocks Shine As ADRs Climb Higher - Finimize

Jun 16, 2025
pulisher
Jun 13, 2025

European ADRs Dip With Some Stocks Rising Above The Crowd - Finimize

Jun 13, 2025
pulisher
May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com South Africa

May 26, 2025
pulisher
May 26, 2025

Cellectis’s SWOT analysis: gene therapy firm’s stock faces pivotal year - Investing.com

May 26, 2025
pulisher
May 21, 2025

Cellectis S.A. announces board change and meeting By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Cellectis S.A. announces board change and meeting - Investing.com

May 21, 2025
pulisher
May 15, 2025

European Equities See Growth In US Trade - Finimize

May 15, 2025
pulisher
May 13, 2025

Cellectis earnings beat by $0.07, revenue topped estimates - Investing.com

May 13, 2025
pulisher
May 12, 2025

Cellectis earnings beat by $0.06, revenue topped estimates - Investing.com India

May 12, 2025
pulisher
Apr 22, 2025

Cellectis Charts Course For 2025 With Boost From AstraZeneca Deal - Barchart.com

Apr 22, 2025
pulisher
Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025
pulisher
Apr 04, 2025

Cellectis stock touches 52-week low at $1.14 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 02, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Cellectis’s SWOT analysis: biotech firm’s stock faces CAR T challenges - Investing.com

Mar 17, 2025
pulisher
Mar 15, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% By Investing.com - Investing.com South Africa

Mar 15, 2025
pulisher
Mar 14, 2025

Cellectis stock touches 52-week low at $1.2 amid market challenges - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Earnings call transcript: Cellectis beats Q4 2024 expectations, stock up 10% - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

What Recent Market Trends Mean for Cosan S.A ADR’s (CSAN) Stock - The News Heater

Mar 14, 2025
pulisher
Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 07, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week - TradingView

Mar 07, 2025
pulisher
Mar 06, 2025

Cellectis stock touches 52-week low at $1.24 amid market challenges - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView

Mar 06, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

StockNews.com Begins Coverage on Cellectis (NASDAQ:CLLS) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Cellectis earnings missed by $0.20, revenue fell short of estimates - Investing.com

Feb 27, 2025
pulisher
Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Cellectis stock touches 52-week low at $1.4 amid market challenges - Investing.com India

Feb 25, 2025
pulisher
Feb 24, 2025

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025 - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 14, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView

Feb 14, 2025
pulisher
Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025
pulisher
Jan 03, 2025

This Penny Stock Has 270% Upside Potential in 2025. Is It a Buy Now? - Barchart.com

Jan 03, 2025

Cellectis Adr (CLLS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):